• Japanese
  • Korean
  • Chinese
Cover Image

Lupus Nephritis Global Clinical Trials Review, H1, 2014

GlobalData's clinical trial report, "Lupus Nephritis Global Clinical Trials Review, H1, 2014" provides data on the Lupus Nephritis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Lupus Nephritis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Lupus Nephritis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

Table of Contents 2

  • List of Tables 4
  • List of Figures 5
  • Introduction 6
  • Lupus Nephritis 6
  • Report Guidance 6
  • Clinical Trials by Region 7
  • Clinical Trials and Average Enrollment by Country 8
  • Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
  • Top Five Countries Contributing to Clinical Trials in Europe 11
  • Top Countries Contributing to Clinical Trials in North America 12
  • Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
  • Top Five Countries Contributing to Clinical Trials in Central and South America 14
  • Clinical Trials by G7 Countries: Proportion of Lupus Nephritis to Immunology Clinical Trials 15
  • Clinical Trials by Phase in G7 Countries 16
  • Clinical Trials in G7 Countries by Trial Status 17
  • Clinical Trials by E7 Countries: Proportion of Lupus Nephritis to Immunology Clinical Trials 18
  • Clinical Trials by Phase in E7 Countries 19
  • Clinical Trials in E7 Countries by Trial Status 20
  • Clinical Trials by Phase 21
  • In Progress Trials by Phase 22
  • Clinical Trials by Trial Status 23
  • Clinical Trials by End Point Status 24
  • Unaccomplished Trials of Lupus Nephritis 25
  • Subjects Recruited Over a Period of Time 27
  • Clinical Trials by Sponsor Type 28
  • Prominent Sponsors 29
  • Top Companies Participating in Lupus Nephritis Therapeutics Clinical Trials 30
  • Prominent Drugs 32
  • Latest Clinical Trials News on Lupus Nephritis 33
  • Oct 15, 2013: Kadmon Announces Development Plans for Selective ROCK 2 Inhibitor, KD025, in Psoriasis, Lupus Nephritis and NASH 33
  • Jun 12, 2013: Teva And Active Biotech Report Positive Results From Phase IIa Study Of Laquinimod In Active Lupus Nephritis 33
  • Jun 28, 2012: Immune Tolerance Network Completes Enrollment Early For ACCESS Lupus Nephritis Study 34
  • Jun 03, 2010: CellCept Reached Positive Results In Phase III Trial In Lupus Nephritis 34
  • Jan 29, 2010: Bindarit A MCP-1/CCL2 Production Inhibitor 35
  • Clinical Trial Profiles 36
  • Clinical Trial Overview of Top Companies 36
  • Novartis AG 36
  • Clinical Trial Overview of Novartis AG 36
  • Astellas Pharma Inc. 37
  • Clinical Trial Overview of Astellas Pharma Inc. 37
  • F. Hoffmann-La Roche Ltd. 38
  • Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 38
  • Biogen Idec Inc. 39
  • Clinical Trial Overview of Biogen Idec Inc. 39
  • Anthera Pharmaceuticals, Inc. 40
  • Clinical Trial Overview of Anthera Pharmaceuticals, Inc. 40
  • Teva Pharmaceutical Industries Limited 41
  • Clinical Trial Overview of Teva Pharmaceutical Industries Limited 41
  • La Jolla Pharmaceutical Company 42
  • Clinical Trial Overview of La Jolla Pharmaceutical Company 42
  • E. Merck KG 43
  • Clinical Trial Overview of E. Merck KG 43
  • Bristol-Myers Squibb Company 44
  • Clinical Trial Overview of Bristol-Myers Squibb Company 44
  • Aurinia Pharmaceuticals Inc. 45
  • Clinical Trial Overview of Aurinia Pharmaceuticals Inc. 45
  • Clinical Trial Overview of Top Institutes / Government 46
  • Nanjing University 46
  • Clinical Trial Overview of Nanjing University 46
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases 47
  • Clinical Trial Overview of National Institute of Arthritis and Musculoskeletal and Skin Diseases 47
  • Sun Yat-sen University 48
  • Clinical Trial Overview of Sun Yat-sen University 48
  • Faculty of Pharmaceutical Sciences, Chulalongkorn University 49
  • Clinical Trial Overview of Faculty of Pharmaceutical Sciences, Chulalongkorn University 49
  • Chinese University of Hong Kong 50
  • Clinical Trial Overview of Chinese University of Hong Kong 50
  • The National Institute of Allergy and Infectious Diseases 51
  • Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases 51
  • All India Institute of Medical Sciences 52
  • Clinical Trial Overview of All India Institute of Medical Sciences 52
  • The National Institute of Diabetes and Digestive and Kidney Diseases 53
  • Clinical Trial Overview of The National Institute of Diabetes and Digestive and Kidney Diseases 53
  • Zhejiang University 54
  • Clinical Trial Overview of Zhejiang University 54
  • The Rogosin Institute 55
  • Clinical Trial Overview of The Rogosin Institute 55
  • Five Key Clinical Profiles 56

Appendix 92

  • Abbreviations 92
  • Definitions 92
  • Research Methodology 93
  • Secondary Research 93
  • About GlobalData 94
  • Contact Us 94
  • Disclaimer 94
  • Source 95

List of Tables

  • Lupus Nephritis Therapeutics, Global, Clinical Trials by Region, 2014* 7
  • Lupus Nephritis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
  • Lupus Nephritis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
  • Lupus Nephritis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
  • Lupus Nephritis Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
  • Lupus Nephritis Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
  • Lupus Nephritis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2014* 13
  • Lupus Nephritis Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014* 14
  • Proportion of Lupus Nephritis to Immunology Clinical Trials, G7 Countries (%), 2014* 15
  • Lupus Nephritis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
  • Lupus Nephritis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
  • Proportion of Lupus Nephritis to Immunology Clinical Trials, E7 Countries (%), 2014* 18
  • Lupus Nephritis Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
  • Lupus Nephritis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
  • Lupus Nephritis Therapeutics, Global, Clinical Trials by Phase, 2014* 21
  • Lupus Nephritis Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22
  • Lupus Nephritis Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
  • Lupus Nephritis Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
  • Lupus Nephritis Therapeutics, Global, Suspended Clinical Trials, 2014* 25
  • Lupus Nephritis Therapeutics, Global, Withdrawn Clinical Trials, 2014* 25
  • Lupus Nephritis Therapeutics, Global, Terminated Clinical Trials, 2014* 26
  • Lupus Nephritis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 27
  • Lupus Nephritis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 28
  • Lupus Nephritis Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 29
  • Lupus Nephritis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 31
  • Lupus Nephritis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 32
  • Lupus Nephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014* 36
  • Lupus Nephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Astellas Pharma Inc., 2014* 37
  • Lupus Nephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2014* 38
  • Lupus Nephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Biogen Idec Inc., 2014* 39
  • Lupus Nephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Anthera Pharmaceuticals, Inc., 2014* 40
  • Lupus Nephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Teva Pharmaceutical Industries Limited, 2014* 41
  • Lupus Nephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by La Jolla Pharmaceutical Company, 2014* 42
  • Lupus Nephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by E. Merck KG, 2014* 43
  • Lupus Nephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2014* 44
  • Lupus Nephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Aurinia Pharmaceuticals Inc., 2014* 45
  • Lupus Nephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Nanjing University, 2014* 46
  • Lupus Nephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Arthritis and Musculoskeletal and Skin Diseases, 2014* 47
  • Lupus Nephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Sun Yat-sen University, 2014* 48
  • Lupus Nephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Faculty of Pharmaceutical Sciences, Chulalongkorn University, 2014* 49
  • Lupus Nephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Chinese University of Hong Kong, 2014* 50
  • Lupus Nephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2014* 51
  • Lupus Nephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by All India Institute of Medical Sciences, 2014* 52
  • Lupus Nephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Diabetes and Digestive and Kidney Diseases, 2014* 53
  • Lupus Nephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Zhejiang University, 2014* 54
  • Lupus Nephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by The Rogosin Institute, 2014* 55

List of Figures

  • Lupus Nephritis Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
  • Lupus Nephritis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
  • Lupus Nephritis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
  • Lupus Nephritis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
  • Lupus Nephritis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
  • Lupus Nephritis Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
  • Lupus Nephritis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2014* 13
  • Lupus Nephritis Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2014* 14
  • Proportion of Lupus Nephritis to Immunology Clinical Trials, G7 Countries (%), 2014* 15
  • Lupus Nephritis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
  • Lupus Nephritis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
  • Proportion of Lupus Nephritis to Immunology Clinical Trials, E7 Countries (%), 2014* 18
  • Lupus Nephritis Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
  • Lupus Nephritis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
  • Lupus Nephritis Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21
  • Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22
  • Lupus Nephritis Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
  • Lupus Nephritis Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
  • Lupus Nephritis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 27
  • Lupus Nephritis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 28
  • Lupus Nephritis Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 29
  • Lupus Nephritis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 30
  • Lupus Nephritis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 32
  • GlobalData Methodology 93
Show More
Pricing
Get Notified
Email me when related reports are published